PFO ACCESS Registry

NCT00583401 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2019-02-04

No results posted yet for this study

Summary

Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.

Conditions

Interventions

DEVICE

Device closure with the AMPLATZER PFO Occluder

Device closure with the AMPLATZER PFO Occluder

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583401 on ClinicalTrials.gov